Literature DB >> 7967634

Handicaps not obligatory in sexual selection for resistance genes.

C Wedekind1.   

Abstract

In previous models of parasite-driven sexual selection, the signals that reveal parasite resistances and that are used in mate choice should be costly to be reliable ("Handicap Principle"). However, sometimes parameter constellations could exist that allow for cheap signals directly revealing the identity of resistance genes. Despite the general conflict of interests between the sexes, sexual selection may, in these cases, have led males to focus on improving their offspring's survival chances instead of trying to get a maximum number of offspring. Males may achieve this by allowing choosy females to optimize costs and benefits of each resistance in the progeny. Multiple signals (such as odours) may serve to encode the necessary information about the identity of resistance genes. As an example, the connection between the major histocompatibility complex and odour-based mate choice in mice could be explained by this hypothesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7967634     DOI: 10.1006/jtbi.1994.1167

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  3 in total

1.  'Good-genes' and 'compatible-genes' effects in an Alpine whitefish and the information content of breeding tubercles over the course of the spawning season.

Authors:  Claus Wedekind; Guillaume Evanno; Davnah Urbach; Alain Jacob; Rudolf Müller
Journal:  Genetica       Date:  2008-03-08       Impact factor: 1.082

2.  Body odour preferences in men and women: do they aim for specific MHC combinations or simply heterozygosity?

Authors:  C Wedekind; S Füri
Journal:  Proc Biol Sci       Date:  1997-10-22       Impact factor: 5.349

3.  Cycle-specific female preferences for visual and non-visual cues in the horse (Equus caballus).

Authors:  Dominik Burger; Charles Meuwly; Selina Thomas; Harald Sieme; Michael Oberthür; Claus Wedekind; Sabine Meinecke-Tillmann
Journal:  PLoS One       Date:  2018-02-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.